Home › Idiopathic Pulmonary Fibrosis › California
Idiopathic Pulmonary Fibrosis clinical trials in California
13 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in California.
Cities in California
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
- University of California, San Francisco, San Francisco
Recruiting
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07673237An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- University of Southern California, Los Angeles
- Newport Native MD, Inc., Newport Beach
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Loma Linda
- Research Site, Los Angeles
- Research Site, Newport Beach
- and 2 more
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Newportnativemd, Inc., Newport Beach
- Palmtree Clinical Research, Palm Springs
- Paradigm Clinical Research Centers, Inc. - Redding, Redding
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 14, 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Paradigm Clinical Research Centers, LLC, San Diego
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Palmtree Clinical Research Inc., Palm Spring
- Paradigm Clinical Research Centers LLC, Redding
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- University of California San Francisco, San Francisco
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511Dose-Escalation Study of Artesunate Patients With IPF
- Stanford University, Stanford
RecruitingPhase 1
Ages 40 and older · All sexes · Updated Aug 11, 2026 · NCT05988463WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Los Angeles, CA, Los Angeles
- WISPer site in Newport Beach, CA, Newport Beach
- WISPer Site in Palm Springs, CA, Palm Springs
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
- Cedars-Sinai, Los Angeles
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Nov 10, 2025 · NCT06567717From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.